ReviewInternational journal of endocrinology and metabolism2027
A 25-year Experience in Quality Assurance: A Methodological Review of Laboratory Quality Control and Quality Assurance in the Tehran Lipid and Glucose Study (TLGS).
Review in International journal of endocrinology and metabolism, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Context: Quality control (QC) and quality assurance (QA) are critical for validating laboratory data in longitudinal studies. The Tehran Lipid and Glucose Study (TLGS), the first large cohort study in Iran, was designed to investigate the incidence of and risk factors for cardiovascular diseases. This article reviews the methodological quality control system used for biochemical testing in the TLGS, with an emphasis on its design, implementation, evaluation, and data stability across study phases. Evidence Acquisition: In this methodological review, internal and external quality-control protocols used in phases 2 to 7 of the TLGS were analyzed and compared with international standards, including those of the Cardiovascular Health Study and the Atherosclerosis Risk in Communities study. Analytical precision data (coefficient of variation [CV%]) for glucose, creatinine, total cholesterol, triglycerides, HDL-C, ALP, ALT, and AST were extracted from a central database, and temporal trends were evaluated. Internal quality control was performed daily using two levels of control sera (normal and abnormal), and interlaboratory accuracy was assessed through participation in an external evaluation program. Results: The mean CV for all tests across the study phases was less than 5% (glucose, 1.95%; creatinine, 3.10%; cholesterol, 2.05%; triglycerides, 2.16%; HDL-C, 3.33%; ALP, 2.10%; ALT, 3.00%; and AST, 3.35%). External quality-control results received an "Excellent" rating for all parameters. The temporal trend in CVs demonstrated stability and a gradual improvement in precision across phases. Levey-Jennings charts, Westgard rules, and weighted regression methods were effective in detecting systematic deviations and enabling prompt corrective action. Conclusions: Establishing a multilevel QC/QA system in the TLGS ensured the stability and accuracy of biochemical data in a large national cohort. The findings indicate that the accuracy of biochemical testing was consistent with international standards and that the resulting data are highly reliable for epidemiological and clinical analyses. This experience may serve as a local model for other longitudinal studies in developing countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.